Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 192564-14-0
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
192564-14-0 |
Appearance:: |
White To Beige Powder |
Molecular Formula:: |
C86H103Cl3N10O34P2 |
Molecular Weight:: |
1989.09000 |
EINECS NO:: |
NA |
MDL NO:: |
NA |
CAS NO:: |
192564-14-0 |
Appearance:: |
White To Beige Powder |
Molecular Formula:: |
C86H103Cl3N10O34P2 |
Molecular Weight:: |
1989.09000 |
EINECS NO:: |
NA |
MDL NO:: |
NA |
Product Description:
Product Name: Oritavancin Diphosphate CAS NO: 192564-14-0
Synonyms:
LY 333328 diphosphate;
oritavancin,LY333328 diphosphate salt;
Chemical & Physical Properties:
Appearance: White to beige powder
Assay :≥99.0%
Storage temp.: -20℃
Oritavancin diphosphate is a glycopeptide analog related to the vancomycin class of antibiotics that inhibits the transpeptidase and transglycosylation steps of bacterial peptidoglycan cell-wall synthesis. The compound was discovered and initially developed by Eli Lilly and Co. The development of the compound was sold to Intermune and then to Targanta which was acquired by The Medicines Company who achieved approval of the drug by the US FDA for the treatment of acute bacterial skin and skin-structure infections caused by gram-positive bacteria. It is also approved for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections.
Oritavancin phosphate can be used in biological study of synthesis, properties, and mechanism of action of new generation of polycyclic glycopeptide antibiotics.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
